HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bogdan Mazur Selected Research

Bogdan Mazur Research Topics

Disease

6Asthma (Bronchial Asthma)
04/2016 - 06/2002
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2002
4Neoplasms (Cancer)
01/2018 - 01/2009
3Atopic Dermatitis (Atopic Eczema)
01/2018 - 08/2007
3Chronic Urticaria
02/2014 - 05/2013
2Leukemia
01/2021 - 03/2004
2Residual Neoplasm
01/2021 - 10/2008
2Chronic Renal Insufficiency
11/2018 - 01/2015
2Obesity
11/2017 - 12/2006
2Multiple Sclerosis
07/2016 - 01/2016
2Prostatic Neoplasms (Prostate Cancer)
08/2010 - 12/2009
2Chronic Kidney Failure (Chronic Renal Failure)
01/2007 - 02/2002
2Rupture
08/2004 - 07/2003
1Anorexia Nervosa
09/2021
1Aneuploidy (Aneuploid)
01/2021
1Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced)
01/2020
1Stroke (Strokes)
11/2018
1Dyslipidemias (Dyslipidemia)
11/2018
13-Hydroxyacyl-CoA Dehydrogenase Deficiency
01/2018
1Iron Deficiencies
01/2018
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2018
1Pleomorphic Adenoma
01/2018
1Myasthenia Gravis
01/2018
1Myoepithelioma
01/2018
1Acinar Cell Carcinoma
01/2018
1Multiple Endocrine Neoplasia Type 2b (MEN 3)
05/2017
1Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2017
1Disease Progression
04/2016
1Relapsing-Remitting Multiple Sclerosis
01/2016
1Adenocarcinoma
01/2016
1Inflammation (Inflammations)
01/2014
1Urticaria (Hives)
05/2012
1Urinary Bladder Neoplasms (Bladder Cancer)
01/2009
1Transfusion Reaction
01/2009
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
10/2008

Drug/Important Bio-Agent (IBA)

7CytokinesIBA
01/2018 - 06/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2009 - 03/2004
4Interleukin-10 (Interleukin 10)IBA
01/2018 - 03/2004
4Interleukin-4 (Interleukin 4)IBA
01/2018 - 06/2005
3Interleukin-8 (Interleukin 8)IBA
04/2016 - 03/2004
3Immunoglobulin E (IgE)IBA
01/2010 - 06/2005
3Interleukin-2 (IL2)IBA
01/2010 - 03/2004
3LigandsIBA
12/2009 - 01/2009
2AntigensIBA
01/2021 - 10/2008
2Insulin (Novolin)FDA Link
01/2020 - 05/2017
2Biomarkers (Surrogate Marker)IBA
01/2018 - 01/2016
2Vitamin DFDA LinkGeneric
01/2018 - 02/2014
2IronIBA
01/2018 - 07/2016
2MelatoninIBA
07/2016 - 06/2002
2ChemokinesIBA
04/2016 - 05/2012
2ChalconesIBA
08/2010 - 12/2009
2Antineoplastic Agents (Antineoplastics)IBA
12/2009 - 02/2009
2HLA-DR Antigens (HLA-DR)IBA
10/2008 - 01/2002
2GhrelinIBA
01/2007 - 12/2006
1Triglycerides (Triacylglycerol)IBA
09/2021
1Biological ProductsIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2020
1Hemoglobins (Hemoglobin)IBA
11/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
11/2018
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
01/2018
1Interleukin-33IBA
01/2018
1AutoantibodiesIBA
01/2018
1Interleukin-1 (Interleukin 1)IBA
01/2018
1hydroxide ionIBA
01/2018
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2018
1Proton Pumps (Proton Pump)IBA
01/2018
1AdipokinesIBA
01/2018
1PhosphatidylserinesIBA
11/2017
1Caspase 8 (Caspase-8)IBA
11/2017
1Caspase 3 (Caspase-3)IBA
11/2017
1Ceruloplasmin (Ferroxidase)IBA
07/2016
1CXC ChemokinesIBA
04/2016
1CC ChemokinesIBA
04/2016
1Chemokine CCL5IBA
04/2016
1Chemokine CXCL9IBA
04/2016
1NitrogenIBA
01/2016
1FlavonoidsIBA
01/2016
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2016
1Chemokine ReceptorsIBA
01/2015
1Advanced Glycation End ProductsIBA
01/2014
1Complement C3 (C3 Complement)IBA
05/2013
1Interleukin-13IBA
01/2010
1licochalcone AIBA
12/2009
1Chalcone (Benzalacetophenone)IBA
12/2009
1isobavachalconeIBA
12/2009
1xanthohumolIBA
12/2009
1buteinIBA
12/2009
1Propolis (Bee Bread)IBA
02/2009
1Cytotoxins (Cytolysins)IBA
01/2009
1Death Domain ReceptorsIBA
01/2009
1PhycoerythrinIBA
01/2009
1Leukocyte Common Antigens (CD45 Antigen)IBA
10/2008

Therapy/Procedure

6Therapeutics
01/2021 - 01/2002
3Chemoprevention
08/2010 - 02/2009
2Drug Therapy (Chemotherapy)
03/2004 - 06/2003
1Induction Chemotherapy
01/2021
1Renal Dialysis (Hemodialysis)
01/2015
1Blood Transfusion (Blood Transfusions)
01/2009
1Blood Component Transfusion
01/2009